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Several evidences have demonstrated 
the role of genetic factors in the patho-
genesis of rheumatoid arthritis (RA) 
(1). 
Genetic variants of candidate genes en-
coding for several cytokines (such as 
IL-1, IL-6, IL-10 and TGF-β), proteases 
(such as protein tyrosine phosphatase 
non-receptor type 22) and other immune/
inflammatory genes (such as macro-
phage protein 1) have been investigated 
with contrasting results (1, 2). Published 
data on the effects of polymorphisms on 
bone-erosive damage in RA have been 
mainly obtained using conventional ra-
diography (2). However, this technique 
is characterised by a lack of sensitivity 
in detecting the presence of erosions in 
early stages of disease (3). 
Musculoskeletal ultrasound (MSUS) is 
an easily available, quick-to-perform 
and relatively low-cost technique that 
has gained an increasing role in the 
evaluation of both inflammation and 
structural damage lesions in RA patients 
(4-8). Particularly, MSUS demonstrated 
a higher sensitivity in the evaluation of 
bone erosive damage, compared to ra-
diographic assessment. 
The association between genetic factors 
and bone erosive damage assessed by 
MSUS has recently been analysed in RA 
patients. After evaluating sonographi-
cally the number of erosions present 
at the level of metacarpophalangeal 
(MCP), proximal interphalangeal (PIP), 
and metatarsophalangeal (MTP) joints, 
a semiquantitative score (ranging from 
0 to 3) has been developed at each joint 
site. By the sum of single joint scores, at 
each anatomic district a MCP-total ero-
sion score (TES), PIP-TES and MTP-
TES (ranging from 0 to 30) were then 
calculated. In addition, a global erosive 
score was obtained by the sum of these 
scores (range 0–90) (9, 10). 
The association between the single 
nucleotide polymorphism (SNP) -308 
A/G of tumour necrosis factor (TNF) 
and the severity of bone erosive dam-
age using MSUS was analysed in a re-
cent study performed in 52 consecutive 
RA patients (9). More specifically, in 
patients carrying the genotype AG or 
AA a significantly higher global TES, 
MCP-TES and MTP-TES were identi-
fied compared with patients carrying the 
GG genotype (28.5±23.7 vs. 38.1±17.1, 
p<0.05; 11.2±8.2 vs. 18±8.4, p=0.027; 
8.2±8 vs. 11.2±6, p<0.05, respectively) 
(9).  
Moreover, the role of SNPs of trans-
forming growth factor beta (TGF-β) 
and interleukin (IL)-6 genes was evalu-
ated and correlated to MSUS-detected 
erosive damage (10). The results of this 
study showed that the TGF-b 869TT 
genotype showed a statistically signifi-
cant lower MTP-TES than those with 
the CC or CT genotype (mean MTP-
TES±SD for 869TT 6.3±5.7 vs. 869CC/
CT 11.7±7.8; p=0.011). Interestingly, 
patients with the TT genotype showed 
dichotomous behaviour that seems 
dependent on autoantibody status. 
In presence of anti-citrullinated pro-
tein antibodies (ACPA) and/or rheuma-
toid factor (RF), the TT genotype was 
associated with lower erosion scores at 
all anatomical sites compared with the 
CC and CT genotypes. Conversely, the 
same 869TT patients showed higher 
erosion scores in the absence of ACPA 
or RF (10). No significant association 
was found when considering the IL-6 
SNP. The authors concluded that the 
TGF-β 869C/T SNP seems involved in 
determining the severity of bone dam-
age in RA, with dichotomous roles ac-
cording to the patient’s autoantibody 
(ACPA and RF) status (10).
In conclusion, recent exploratory stud-
ies suggest that the use of a sensitive 
technique such as MSUS can help to 
identify the association between genetic 
factors and bone erosive damage. This 
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issue has a relevant importance consid-
ering the possibility to identify the mark-
er of severity of disease and the subset 
of patients requiring a more aggressive 
treatment. Further studies conducted in 
larger populations and prospective de-
signs are needed to better clarify these 
complex aspects of RA.
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